Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Curr Treat Options Neurol. 2012 Aug;14(4):332–347. doi: 10.1007/s11940-012-0180-y
Special points VNS is effective in reducing seizure frequency in patients with chronic refractory epilepsy, with more than 40 % of implanted patients achieving a 50 % or greater reduction in seizure frequency [97], and often leads to improved quality of life, possibly due to reduction in AED load [4347, 98, 99].
Complications Dysphonia, dysphagia, throat pain/dysesthesias.
Cost Expensive over a short term but highly cost-effective longitudinally.